# Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate

> **NCT05647447** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Kansas Medical Center**

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **DRUG:** Osanetant

## Key facts

- **NCT ID:** NCT05647447
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-03
- **Primary completion:** 2023-09-22
- **Final completion:** 2023-10-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Development of the drug program has been discontinued
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647447, "Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05647447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*